Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000691750 | SCV000819540 | uncertain significance | Herpes simplex encephalitis, susceptibility to, 3 | 2021-10-18 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with glutamine at codon 163 of the TRAF3 protein (p.Arg163Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with TRAF3-related conditions. This variant is not present in population databases (ExAC no frequency). |